| MeSH term | MeSH ID | Detail |
|---|---|---|
| Brain Neoplasms | D001932 | 15 associated lipids |
| Breast Neoplasms | D001943 | 24 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
| Candidiasis | D002177 | 3 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Cerebellar Neoplasms | D002528 | 9 associated lipids |
HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Am. J. Physiol. Heart Circ. Physiol. (3)
- Proc. Natl. Acad. Sci. U.S.A. (1)
- Stem Cells Transl Med (1)
- Others (13)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| GarcÃa-Closas M et al. | Established breast cancer risk factors by clinically important tumour characteristics. | 2006 | Br. J. Cancer | pmid:16755295 |
| Hsieh JL et al. | Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5. | 2003 | Br. J. Cancer | pmid:12778082 |
| Terry G et al. | The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. | 2004 | Br. J. Cancer | pmid:15570308 |
| Mellado B et al. | Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. | 2009 | Br. J. Cancer | pmid:19755998 |
| Kupryjańczyk J et al. | Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. | 2003 | Br. J. Cancer | pmid:12644821 |
| Shetty G et al. | Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. | 2006 | Br. J. Cancer | pmid:16622450 |
| Hanly AM et al. | Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. | 2006 | Br. J. Cancer | pmid:16622452 |
| Scott IS et al. | A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. | 2006 | Br. J. Cancer | pmid:16622441 |
| Millar EK et al. | BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. | 2009 | Br. J. Cancer | pmid:19066611 |
| Pamecha V et al. | Effect of portal vein embolisation on the growth rate of colorectal liver metastases. | 2009 | Br. J. Cancer | pmid:19209170 |
| Aoyagi Y et al. | Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. | 2004 | Br. J. Cancer | pmid:15365564 |
| Grabowski P et al. | Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:12556969 |
| Clark SE et al. | Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. | 2011 | Br. J. Cancer | pmid:21139586 |
| Fareed KR et al. | Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. | 2010 | Br. J. Cancer | pmid:20461087 |
| Rehman I et al. | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. | 2004 | Br. J. Cancer | pmid:15280928 |
| McFadyen MC et al. | Cytochrome P450 CYP1B1 activity in renal cell carcinoma. | 2004 | Br. J. Cancer | pmid:15280921 |
| Bibi R et al. | A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. | 2006 | Br. J. Cancer | pmid:17031402 |
| Bruland O et al. | Gene expression reveals two distinct groups of anal carcinomas with clinical implications. | 2008 | Br. J. Cancer | pmid:18349847 |
| Wu X et al. | Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. | 2009 | Br. J. Cancer | pmid:19142186 |
| Puppa G et al. | Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. | 2007 | Br. J. Cancer | pmid:17375048 |
| Schmitz M et al. | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. | 2007 | Br. J. Cancer | pmid:17375044 |
| Hiraoka K et al. | Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. | 2006 | Br. J. Cancer | pmid:16421594 |
| Kazama S et al. | Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. | 2006 | Br. J. Cancer | pmid:16404429 |
| Arnould L et al. | Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? | 2006 | Br. J. Cancer | pmid:16404427 |
| Went P et al. | Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. | 2006 | Br. J. Cancer | pmid:16404366 |
| Zheng BY et al. | Detection of adeno-associated virus type 2 genome in cervical carcinoma. | 2006 | Br. J. Cancer | pmid:16736006 |
| Koljonen V et al. | Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. | 2009 | Br. J. Cancer | pmid:19755994 |
| Shehata M et al. | Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. | 2009 | Br. J. Cancer | pmid:19755991 |
| Ebihara Y et al. | DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15188007 |
| Julien C et al. | Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia. | 2004 | Br. J. Cancer | pmid:15188003 |
| Sigstad E et al. | A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. | 2002 | Br. J. Cancer | pmid:12107839 |
| Fenton BM et al. | Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis. | 2002 | Br. J. Cancer | pmid:12087474 |
| Brown NJ et al. | Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. | 2002 | Br. J. Cancer | pmid:12087471 |
| Barboro P et al. | Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. | 2009 | Br. J. Cancer | pmid:19401687 |
| Sasiadek MM et al. | Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. | 2004 | Br. J. Cancer | pmid:15083191 |
| Frei KA et al. | Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. | 2004 | Br. J. Cancer | pmid:14970857 |
| Reitsamer R et al. | 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up. | 2004 | Br. J. Cancer | pmid:15083184 |
| Weigelt B et al. | Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. | 2004 | Br. J. Cancer | pmid:15083181 |
| Sriraksa R et al. | CpG-island methylation study of liver fluke-related cholangiocarcinoma. | 2011 | Br. J. Cancer | pmid:21448164 |
| Otake M et al. | Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma. | 2003 | Br. J. Cancer | pmid:12915887 |
| Hussain SA et al. | Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. | 2007 | Br. J. Cancer | pmid:17213826 |
| Hosono S et al. | Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. | 2007 | Br. J. Cancer | pmid:17211477 |
| Griffiths RW et al. | Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. | 2005 | Br. J. Cancer | pmid:16222313 |
| Takemoto S et al. | Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. | 2009 | Br. J. Cancer | pmid:19638983 |
| Lagadec P et al. | Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells. | 2008 | Br. J. Cancer | pmid:18182997 |
| Mitra A et al. | Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. | 2008 | Br. J. Cancer | pmid:18182994 |
| Frost K et al. | Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma? | 2011 | Br. J. Cancer | pmid:21407220 |
| Hao J et al. | Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. | 2010 | Br. J. Cancer | pmid:20736947 |
| Ash S et al. | Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation. | 2010 | Br. J. Cancer | pmid:20978501 |
| Beresford MJ et al. | The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. | 2006 | Br. J. Cancer | pmid:17160082 |
| Prowatke I et al. | Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. | 2007 | Br. J. Cancer | pmid:17146477 |
| Chen H et al. | Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. | 2009 | Br. J. Cancer | pmid:19603017 |
| Ord JJ et al. | Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. | 2005 | Br. J. Cancer | pmid:16052224 |
| Savic S et al. | Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. | 2008 | Br. J. Cancer | pmid:18087280 |
| Mellor HR et al. | A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. | 2005 | Br. J. Cancer | pmid:16052217 |
| Mizukami Y et al. | Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. | 2008 | Br. J. Cancer | pmid:18087278 |
| Wu F et al. | A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. | 2003 | Br. J. Cancer | pmid:14676799 |
| Kostourou V et al. | The role of tumour-derived iNOS in tumour progression and angiogenesis. | 2011 | Br. J. Cancer | pmid:21139581 |
| Hassel JC et al. | MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. | 2010 | Br. J. Cancer | pmid:20736948 |
| Lee JY et al. | Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. | 2011 | Br. J. Cancer | pmid:21364590 |
| Wu CF et al. | Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract. | 2010 | Br. J. Cancer | pmid:20736946 |
| Rachagani S et al. | Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. | 2011 | Br. J. Cancer | pmid:21364589 |
| Cui T et al. | DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. | 2011 | Br. J. Cancer | pmid:21364582 |
| Verschoyle RD et al. | Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. | 2007 | Br. J. Cancer | pmid:17211473 |
| Knijn N et al. | KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. | 2011 | Br. J. Cancer | pmid:21364579 |
| Dunn J et al. | Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. | 2009 | Br. J. Cancer | pmid:19536096 |
| Cocco E et al. | Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. | 2009 | Br. J. Cancer | pmid:19536090 |
| Alain T et al. | The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. | 2006 | Br. J. Cancer | pmid:17047650 |
| Tonini G et al. | Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. | 2005 | Br. J. Cancer | pmid:15928668 |
| Donnelly ET et al. | Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. | 2005 | Br. J. Cancer | pmid:15928667 |
| Ord JJ et al. | Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma. | 2005 | Br. J. Cancer | pmid:15928663 |
| Milde-Langosch K et al. | Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. | 2005 | Br. J. Cancer | pmid:15928662 |
| Staibano S et al. | OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. | 2007 | Br. J. Cancer | pmid:17987038 |
| Ma S et al. | O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. | 2003 | Br. J. Cancer | pmid:14562026 |
| Mellor P et al. | Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. | 2007 | Br. J. Cancer | pmid:17726466 |
| Yamamoto E et al. | Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. | 2007 | Br. J. Cancer | pmid:17971775 |
| Debrock G et al. | A phase II trial with rosiglitazone in liposarcoma patients. | 2003 | Br. J. Cancer | pmid:14562008 |
| Jacques C et al. | Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours. | 2009 | Br. J. Cancer | pmid:19536094 |
| Carpenter B et al. | Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. | 2006 | Br. J. Cancer | pmid:16953238 |
| Brown MD et al. | Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. | 2006 | Br. J. Cancer | pmid:16523199 |
| Larsson A et al. | Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. | 2011 | Br. J. Cancer | pmid:21829192 |
| Liu W et al. | Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. | 2004 | Br. J. Cancer | pmid:15083195 |
| Villers A et al. | Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). | 2003 | Br. J. Cancer | pmid:12915903 |
| Weng WH et al. | Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. | 2003 | Br. J. Cancer | pmid:12915885 |
| Matsumoto N et al. | Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. | 2003 | Br. J. Cancer | pmid:12915883 |
| Ajisaka H and Miwa K | Micrometastases in sentinel nodes of gastric cancer. | 2003 | Br. J. Cancer | pmid:12915877 |
| Loubeyre P et al. | Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital. | 2009 | Br. J. Cancer | pmid:19401685 |
| Ieta K et al. | CEACAM6 gene expression in intrahepatic cholangiocarcinoma. | 2006 | Br. J. Cancer | pmid:16868542 |
| Modjtahedi H et al. | Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. | 2012 | Br. J. Cancer | pmid:22315050 |
| Sersa G et al. | Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. | 2008 | Br. J. Cancer | pmid:18182988 |
| de Graeff P et al. | The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. | 2008 | Br. J. Cancer | pmid:18628764 |
| Jekimovs CR et al. | Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. | 2005 | Br. J. Cancer | pmid:15700044 |
| te Velde EA et al. | Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. | 2005 | Br. J. Cancer | pmid:15700042 |
| Blancato J et al. | Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. | 2004 | Br. J. Cancer | pmid:15083194 |
| Roka F et al. | Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. | 2005 | Br. J. Cancer | pmid:15700039 |
| Gerber SA et al. | Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. | 2003 | Br. J. Cancer | pmid:12778077 |
| Wagenaar-Miller RA et al. | Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. | 2003 | Br. J. Cancer | pmid:12778076 |
| Tonetti DA et al. | Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. | 2003 | Br. J. Cancer | pmid:12778068 |
| Gisselsson D et al. | Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. | 2002 | Br. J. Cancer | pmid:12107843 |
| Subramaniam V et al. | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 2003 | Br. J. Cancer | pmid:14562029 |